Patent · US Active

Methods and compositions

US12415862B2 · kind B2 · utility

0Cited by

1References

20Claims

0Family size

Assignee

ALLIGATOR BIOSCIENCE AB · SE

Inventors

Peter Ellmark · Lund, SE
Per Norlen · Lund, SE
Karin Hagerbrand · Hjärup, SE

Key dates

Filing date	Mar 30, 2021
Grant date	Sep 16, 2025
Priority date	—
Expiry date	Jun 3, 2042

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/705
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides polypeptides capable of targeting antigens, such as neoantigens, to particular immune cells, and associated therapeutic methods. In particular embodiments, the polypeptides are antibodies or antibody-based polypeptides.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.